Guardian Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.76M Sell
10,542
-132
-1% -$34.8K 0.24% 73
2026
Q2
$2.36M Sell
10,674
-9,236
-46% -$2.55M 0.21% 80
2026
Q1
$5.89M Buy
19,910
+91
+0.5% +$27K 0.49% 53
2025
Q4
$5.82M Buy
19,819
+3,344
+20% +$909K 0.47% 54
2025
Q3
$4.38M Buy
16,475
+1,900
+13% +$517K 0.37% 67
2025
Q2
$4.02M Buy
14,575
+360
+3% +$97.9K 0.36% 69
2025
Q1
$3.72M Sell
14,215
-1,570
-10% -$387K 0.38% 72
2024
Q4
$3.62M Buy
+15,785
New +$3.63M 0.37% 68

Other funds holding CME

Guardian Partners's CME Position: Q3 2026 in Review

Guardian Partners reduced its CME Group (CME) stake by 1.2% in Q3 2026, selling an estimated $34.8K and leaving 10,542 shares worth $2.76M. The position accounts for 0.24% of the portfolio, ranked #73.

Guardian Partners first reported a position in CME in Q4 2024 and has held it in 8 quarters since. The position peaked at $5.89M in Q1 2026. 635 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Guardian Partners held 10,542 shares of CME Group worth $2.76M as of Q3 2026.
  • Guardian Partners sold 132 CME Group shares in Q3 2026, an estimated $34.8K.
  • CME Group made up 0.24% of Guardian Partners's portfolio in Q3 2026, its #73 holding.
  • Guardian Partners first reported a position in CME Group in Q4 2024 and has held it in 8 quarters since.
  • Guardian Partners's CME Group position peaked at $5.89M in Q1 2026.
  • 635 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Guardian Partners's 13F filing for Q3 2026, filed 21 Oct 2026.